MoneyWorks4Me

Wockhardt informs about press release

11 Dec 2023 Evaluate
Wockhardt has informed that it enclosed the Press Release titled ‘Wockhardt announces successful completion of pivotal Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873’, which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..